| 2433 |
Decrease, Telomere attrition
Short Name
Telomere attrition
|
0 |
Molecular |
Jul 9, 2026 |
Jul 9, 2026 |
None
|
| 2434 |
Disruption, Mitochondrial dysfunction
Short Name
Mitochondrial dysfunction
|
0 |
Cellular |
Jul 9, 2026 |
Jul 9, 2026 |
645: Binding and activation of AhR lead to cardiovascular aging
|
| 2435 |
Increase, Myocardial and vascular structural remodeling
Short Name
Myocardial and vascular structural remodeling
|
0 |
Tissue |
Jul 9, 2026 |
Jul 9, 2026 |
645: Binding and activation of AhR lead to cardiovascular aging
|
| 2436 |
Increase, Systemic inflammation
Short Name
Systemic inflammation
|
0 |
Cellular |
Jul 9, 2026 |
Jul 9, 2026 |
645: Binding and activation of AhR lead to cardiovascular aging
|
| 2437 |
Increase, Blood pressure elevation
Short Name
Blood pressure elevation
|
0 |
Tissue |
Jul 9, 2026 |
Jul 9, 2026 |
645: Binding and activation of AhR lead to cardiovascular aging
|
| 2438 |
Increase, Cardiovascular aging
Short Name
Cardiovascular aging
|
0 |
Individual |
Jul 9, 2026 |
Jul 9, 2026 |
645: Binding and activation of AhR lead to cardiovascular aging
|
| 2439 |
Increase, Telomere attrition
Short Name
Increase, Telomere attrition
|
0 |
Molecular |
Jul 9, 2026 |
Jul 9, 2026 |
645: Binding and activation of AhR lead to cardiovascular aging
|
| 2440 |
Increase, Hepatic inflammation
Short Name
Hepatic inflammation
|
0 |
Tissue |
Jul 9, 2026 |
Jul 9, 2026 |
646: Binding and activation of AhR/PPARγ lead to lipid metabolism disorders
|
| 2441 |
Increased , Fatty acid synthesis and transport
Short Name
Increased fatty acid synthesis and transport
|
0 |
Tissue |
Jul 9, 2026 |
Jul 9, 2026 |
646: Binding and activation of AhR/PPARγ lead to lipid metabolism disorders
|
| 2442 |
Increase, Abnormal lipid accumulation
Short Name
Abnormal lipid accumulation
|
0 |
Organ |
Jul 9, 2026 |
Jul 9, 2026 |
646: Binding and activation of AhR/PPARγ lead to lipid metabolism disorders
|
| 2443 |
Increase, Hepatocyte injury
Short Name
Hepatocyte injury
|
0 |
Tissue |
Jul 9, 2026 |
Jul 9, 2026 |
646: Binding and activation of AhR/PPARγ lead to lipid metabolism disorders
|